A citation-based method for searching scientific literature

Massimo Iacoviello, Alberto Palazzuoli, Edoardo Gronda. Eur J Clin Invest 2021
Times Cited: 3







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Hélène Nougué, Théo Pezel, François Picard, Malha Sadoune, Mattia Arrigo, Florence Beauvais, Jean-Marie Launay, Alain Cohen-Solal, Nicolas Vodovar, Damien Logeart. Eur J Heart Fail 2019
73
66

Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
Eric J Velazquez, David A Morrow, Adam D DeVore, Carol I Duffy, Andrew P Ambrosy, Kevin McCague, Ricardo Rocha, Eugene Braunwald. N Engl J Med 2019
420
66

Spironolactone for heart failure with preserved ejection fraction.
Bertram Pitt, Marc A Pfeffer, Susan F Assmann, Robin Boineau, Inder S Anand, Brian Claggett, Nadine Clausell, Akshay S Desai, Rafael Diaz, Jerome L Fleg,[...]. N Engl J Med 2014
66

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Anne Pernille Ofstad, Egon Pfarr, Waheed Jamal,[...]. Lancet 2020
328
66

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
Thomas M Maddox, James L Januzzi, Larry A Allen, Khadijah Breathett, Javed Butler, Leslie L Davis, Gregg C Fonarow, Nasrien E Ibrahim, JoAnn Lindenfeld, Frederick A Masoudi,[...]. J Am Coll Cardiol 2021
189
66


Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization.
Akshay S Desai, Brian L Claggett, Milton Packer, Michael R Zile, Jean L Rouleau, Karl Swedberg, Victor Shi, Martin Lefkowitz, Randall Starling, John Teerlink,[...]. J Am Coll Cardiol 2016
71
66

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Inder S Anand, Junbo Ge, Carolyn S P Lam, Aldo P Maggioni, Felipe Martinez, Milton Packer, Marc A Pfeffer, Burkert Pieske,[...]. N Engl J Med 2019
680
66

Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Akshay S Desai, Scott D Solomon, Amil M Shah, Brian L Claggett, James C Fang, Joseph Izzo, Kevin McCague, Cheryl A Abbas, Ricardo Rocha, Gary F Mitchell. JAMA 2019
104
66

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
66

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
66

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.
Rolf Wachter, Michele Senni, Jan Belohlavek, Ewa Straburzynska-Migaj, Klaus K Witte, Zhanna Kobalava, Candida Fonseca, Eva Goncalvesova, Yuksel Cavusoglu, Alberto Fernandez,[...]. Eur J Heart Fail 2019
92
66

Heart failure drug treatment: the fantastic four.
Johann Bauersachs. Eur Heart J 2021
30
66

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
418
66

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
986
66

Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.
James L Januzzi, Margaret F Prescott, Javed Butler, G Michael Felker, Alan S Maisel, Kevin McCague, Alexander Camacho, Ileana L Piña, Ricardo A Rocha, Amil M Shah,[...]. JAMA 2019
186
66

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
Paul W Armstrong, Burkert Pieske, Kevin J Anstrom, Justin Ezekowitz, Adrian F Hernandez, Javed Butler, Carolyn S P Lam, Piotr Ponikowski, Adriaan A Voors, Gang Jia,[...]. N Engl J Med 2020
292
66

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, Milton Packer, Michael Zile, Karl Swedberg, Jean Rouleau, Marc A Pfeffer, Akshay Desai, Lars H Lund,[...]. Circulation 2020
131
66

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
33

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.
Michele Senni, Walter J Paulus, Antonello Gavazzi, Alan G Fraser, Javier Díez, Scott D Solomon, Otto A Smiseth, Marco Guazzi, Carolyn S P Lam, Aldo P Maggioni,[...]. Eur Heart J 2014
224
33

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Salim Yusuf, Bertram Pitt, Clarence E Davis, William B Hood, Jay N Cohn. N Engl J Med 1991
33

Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Tim Heise, Roberto Bizzotto, Andrea Mari, Thomas R Pieber, Elza Muscelli. Diabetes 2016
315
33

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.
Milton Packer, Michael B Fowler, Ellen B Roecker, Andrew J S Coats, Hugo A Katus, Henry Krum, Paul Mohacsi, Jean L Rouleau, Michal Tendera, Christoph Staiger,[...]. Circulation 2002
793
33

Design of a prospective patient-level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure.
Milton Packer, Javed Butler, Gerasimos Filippatos, Faiez Zannad, Joao Pedro Ferreira, Cordula Zeller, Martina Brueckmann, Waheed Jamal, Stuart J Pocock, Stefan D Anker. Eur J Heart Fail 2020
9
33

Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.
Scott D Solomon, Brian Claggett, Eldrin F Lewis, Akshay Desai, Inder Anand, Nancy K Sweitzer, Eileen O'Meara, Sanjiv J Shah, Sonja McKinlay, Jerome L Fleg,[...]. Eur Heart J 2016
218
33

Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis.
Vojtech Melenovsky, Jiri Petrak, Tomas Mracek, Jan Benes, Barry A Borlaug, Hana Nuskova, Tomas Pluhacek, Jaroslav Spatenka, Jana Kovalcikova, Zdenek Drahota,[...]. Eur J Heart Fail 2017
117
33

Ferric carboxymaltose in patients with heart failure and iron deficiency.
Stefan D Anker, Josep Comin Colet, Gerasimos Filippatos, Ronnie Willenheimer, Kenneth Dickstein, Helmut Drexler, Thomas F Lüscher, Boris Bart, Waldemar Banasiak, Joanna Niegowska,[...]. N Engl J Med 2009
33

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Christopher B Granger, John J V McMurray, Salim Yusuf, Peter Held, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Marc A Pfeffer, Karl Swedberg. Lancet 2003
33

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Iacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P Abraham, Ahmad Masri, Pablo Garcia-Pavia, Sara Saberi, Neal K Lakdawala, Matthew T Wheeler, Anjali Owens,[...]. Lancet 2020
128
33

Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function.
Martijn F Hoes, Niels Grote Beverborg, J David Kijlstra, Jeroen Kuipers, Dorine W Swinkels, Ben N G Giepmans, Richard J Rodenburg, Dirk J van Veldhuisen, Rudolf A de Boer, Peter van der Meer. Eur J Heart Fail 2018
117
33

Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany.
Rolf Wachter, Ana F Fonseca, Bogdan Balas, Elisabeth Kap, Johanna Engelhard, Raymond Schlienger, Sven Klebs, Sara Bruce Wirta, Karel Kostev. Eur J Heart Fail 2019
24
33

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
Salim Yusuf, Marc A Pfeffer, Karl Swedberg, Christopher B Granger, Peter Held, John J V McMurray, Eric L Michelson, Bertil Olofsson, Jan Ostergren. Lancet 2003
33

Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.
Fady I Malik, James J Hartman, Kathleen A Elias, Bradley P Morgan, Hector Rodriguez, Katjusa Brejc, Robert L Anderson, Sandra H Sueoka, Kenneth H Lee, Jeffrey T Finer,[...]. Science 2011
349
33

Iron deficiency as energetic insult to skeletal muscle in chronic diseases.
Magdalena Dziegala, Krystian Josiak, Monika Kasztura, Kamil Kobak, Stephan von Haehling, Waldemar Banasiak, Stefan D Anker, Piotr Ponikowski, Ewa Jankowska. J Cachexia Sarcopenia Muscle 2018
40
33

Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week.
Mitchell A Psotka, Stephen S Gottlieb, Gary S Francis, Larry A Allen, John R Teerlink, Kirkwood F Adams, Giuseppe M C Rosano, Patrizio Lancellotti. J Am Coll Cardiol 2019
54
33


Heart failure.
Eugene Braunwald. JACC Heart Fail 2013
486
33

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, Dirk J Van Veldhuisen, Aleksandr Parkhomenko, Joszef Borbola, Alain Cohen-Solal, Dan Dumitrascu, Roberto Ferrari, Philippe Lechat,[...]. Eur Heart J 2005
925
33

Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF.
Pooja Dewan, Scott D Solomon, Pardeep S Jhund, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, David L DeMets, Marc S Sabatine,[...]. Eur J Heart Fail 2020
21
33

Eplerenone in patients with systolic heart failure and mild symptoms.
Faiez Zannad, John J V McMurray, Henry Krum, Dirk J van Veldhuisen, Karl Swedberg, Harry Shi, John Vincent, Stuart J Pocock, Bertram Pitt. N Engl J Med 2011
33

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
Stefan D Anker, Bridget-Anne Kirwan, Dirk J van Veldhuisen, Gerasimos Filippatos, Josep Comin-Colet, Frank Ruschitzka, Thomas F Lüscher, Gregory P Arutyunov, Michael Motro, Claudio Mori,[...]. Eur J Heart Fail 2018
176
33

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.
John R Teerlink, G Michael Felker, John J V McMurray, Scott D Solomon, Kirkwood F Adams, John G F Cleland, Justin A Ezekowitz, Assen Goudev, Peter Macdonald, Marco Metra,[...]. Lancet 2016
150
33

Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial.
Adam D DeVore, Eugene Braunwald, David A Morrow, Carol I Duffy, Andrew P Ambrosy, Hrishikesh Chakraborty, Kevin McCague, Ricardo Rocha, Eric J Velazquez. JAMA Cardiol 2020
28
33

Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
Natalie A Mordi, Ify R Mordi, Jagdeep S Singh, Rory J McCrimmon, Allan D Struthers, Chim C Lang. Circulation 2020
54
33

Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Alice M Jackson, Pooja Dewan, Inder S Anand, Jan Bělohlávek, Olof Bengtsson, Rudolf A de Boer, Michael Böhm, David W Boulton, Vijay K Chopra, David L DeMets,[...]. Circulation 2020
48
33

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Mark C Petrie, Subodh Verma, Kieran F Docherty, Silvio E Inzucchi, Inder Anand, Jan Belohlávek, Michael Böhm, Chern-En Chiang, Vijay K Chopra, Rudolf A de Boer,[...]. JAMA 2020
155
33

Iron deficiency: an ominous sign in patients with systolic chronic heart failure.
Ewa A Jankowska, Piotr Rozentryt, Agnieszka Witkowska, Jolanta Nowak, Oliver Hartmann, Beata Ponikowska, Ludmila Borodulin-Nadzieja, Waldemar Banasiak, Lech Polonski, Gerasimos Filippatos,[...]. Eur Heart J 2010
362
33

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Mathew S Maurer, Jeffrey H Schwartz, Balarama Gundapaneni, Perry M Elliott, Giampaolo Merlini, Marcia Waddington-Cruz, Arnt V Kristen, Martha Grogan, Ronald Witteles, Thibaud Damy,[...]. N Engl J Med 2018
790
33

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial.
Stefan D Anker, Javed Butler, Gerasimos Filippatos, Muhammad Shahzeb Khan, Nikolaus Marx, Carolyn S P Lam, Sven Schnaidt, Anne Pernille Ofstad, Martina Brueckmann, Waheed Jamal,[...]. Circulation 2021
65
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.